论文部分内容阅读
慢性肾脏病(CKD)是严重威胁人类健康的常见慢性病,病因多种多样,高血糖是CKD发展的主要原因之一。2型糖尿病常合并CKD,由糖尿病所引发的肾脏病被称为糖尿病肾脏病(DKD)。降糖治疗至关重要,然而,由于CKD的特殊性,很多临床医生在选择口服降糖药时畏手畏脚,不知该如何选择。中国医师协会内分泌代谢科医师分会2013年专门发布了《2型糖尿病合并慢性肾脏病患者口服降糖药用药原则中国专家共识》,我们进行了节选,希望对广大基层医生起到指导作用。
Chronic kidney disease (CKD) is a common chronic disease that seriously threatens human health. The causes are various and hyperglycemia is one of the major causes of CKD. Type 2 diabetes is often associated with CKD and the diabetic nephropathy is called diabetic nephropathy (DKD). Hypoglycemic treatment is crucial, however, because of the particularity of CKD, many clinicians are afraid of their feet when choosing oral hypoglycemic agents, I do not know how to choose. The Chinese Society of Endocrinology and Metabolism Branch of the Chinese Association of Physicians and Surgeons released a special Chinese expert consensus on the principle of oral hypoglycemic agents in patients with type 2 diabetes and chronic kidney disease in 2013. We conducted an excerpt and hoped to play a guiding role for the grassroots physicians.